Julphar to Build Pharmaceutical Plant in Jeddah, Awsat Says

Gulf Pharmaceutical Industries, also known as Julphar, signed an agreement with Cigalah Group to build a pharmaceutical plant in Jeddah, Asharq al-Awsat reported, citing Julphar’s Chairman Faisal Al Qasimi.

The plant, with an investment of $40 million, will start commercial production in 2014, the newspaper said.

To contact the reporter on this story: Mourad Haroutunian in Riyadh at mharoutunian@bloomberg.net

To contact the editor responsible for this story: Shaji Mathew at shajimathew@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.